Efficacy of repurposed antiviral drugs: Lessons from COVID-19
Miguel Ángel Martı́nez
Topics & Concepts
RepurposingDrug repositioningCoronavirus disease 2019 (COVID-19)CoronavirusDrugDrug discoveryPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseAntiviral drugMedicine2019-20 coronavirus outbreakDrug developmentEx vivoVirologyHydroxychloroquinePharmacologyInfectious disease (medical specialty)BiologyIn vivoBioinformaticsOutbreakBiotechnologyInternal medicineEcologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPARP inhibition in cancer therapy